Showing results (31-40 of 219) with videos related to
Sort By:
Pageof 22
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 20, 2011
Real-world rates of in-hospital and postdischarge deep-vein thrombosis and pulmonary embolism in at-risk medical patients in the United StatesAlpesh N Amin, Jay Lin, Stephen Thompson, et al.Journal of Thrombosis and Thrombolysis|October 2, 2009
Are surgical patients at risk of venous thromboembolism currently meeting the Surgical Care Improvement Project performance measure for appropriate and timely prophylaxis?Steven B Deitelzweig, Jay Lin, Mohamed Hussein, et al.Thrombosis and Haemostasis|November 8, 2008
Comparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolismSteven B Deitelzweig, Russ Becker, Jay Lin, et al.Clinical Lymphoma, Myeloma & Leukemia|November 26, 2015
Use of Real-World Claim Databases to Assess Prevalence of Comorbid Conditions Relevant to the Treatment of Chronic Myelogenous Leukemia Based on National Comprehensive Network Treatment GuidelinesElias Jabbour, Dinara Makenbaeva, Melissa Lingohr-Smith, et al.American Journal of Clinical Oncology|November 19, 2015
Impact of Genetic Mutations and Health Plan Access to Therapies on Treatment Response and Drug Costs Related to Tyrosine Kinase Inhibitor Treatment Among Patients With Chronic Myelogenous LeukemiaElias Jabbour, Dinara Makenbaeva, Melissa Lingohr-Smith, et al.Journal of Thrombosis and Thrombolysis|May 30, 2009
Rates of symptomatic venous thromboembolism in US surgical patients: a retrospective administrative database studyAlex C Spyropoulos, Mohammed Hussein, Jay Lin, et al.Journal of Medical Economics|March 14, 2017
Healthcare and economic burden of adverse events among patients with chronic myelogenous leukemia treated with BCR-ABL1 tyrosine kinase inhibitorsJay Lin, Dinara Makenbaeva, Melissa Lingohr-Smith, et al.Journal of Hospital Medicine|October 15, 2009
Inpatient thromboprophylaxis use in U.S. hospitals: adherence to the seventh American College of Chest Physician's recommendations for at-risk medical and surgical patientsAlpesh N Amin, Stephen Stemkowski, Jay Lin, et al.Carbohydrate Research|November 16, 2002
Characterization of cyanobacterial glycogen isolated from the wild type and from a mutant lacking of branching enzymeSang-Ho Yoo, Martin H Spalding, Jay-lin JaneJournal of Women'S Health (2002)|February 4, 2017
Comparison of Healthcare Costs Among Commercially Insured Women in the United States Who Underwent Hysteroscopic Sterilization Versus Laparoscopic Bilateral Tubal Ligation SterilizationPatricia I Carney, Jianying Yao, Jay Lin, et al.Pageof 22